Ribomic Inc. reported earnings results for the nine months ended December 31, 2023. For the nine months, the company reported net loss was JPY 802.77 million compared to JPY 1,476.68 million a year ago. Basic loss per share from continuing operations was JPY 22.5 compared to JPY 49.87 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86 JPY | +3.61% | +4.88% | -20.37% |
1st Jan change | Capi. | |
---|---|---|
-20.37% | 20.25M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- 4591 Stock
- News Ribomic Inc.
- Ribomic Inc. Reports Earnings Results for the Nine Months Ended December 31, 2023